People

Rui Wu

Executive vice president responsible for research, preclinical development and CMC at Graviton Bioscience. Involved since the company’s inception; previously led preclinical research and CMC at Equilibre and small molecule retomer drug discovery at MeiraGTx. Holds a PhD in biochemistry with a neuroscience research background.